Fear, anxiety and embarrassment stop women going for breast screening

November 9, 2011, Cancer Research UK

(Medical Xpress) -- Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.

Researchers from the Gateshead Foundation Trust looked at why breast screening uptake varies between different areas covered by their screening programme.

They found that even in areas of high deprivation – a known reason for low breast screening uptake – GP practices’ screening rates still differed by over 10 per cent.

By speaking to in focus groups they found that fear, anxiety and were the main reasons women gave for not attending breast screening. The other reason given was denial of the disease, saying cancer would never happen to them.

Further work also showed women were not aware that breast cancer risk increases with age. And – worryingly – most women could only name two symptoms* of the disease.

Julie Tucker, lead author from the Gateshead Foundation Trust, said: “Our results show that more must be done to tackle the low uptake of screening and poor awareness of breast cancer symptoms. We must ensure that GPs, nurses and health professionals feel able to talk to women about the pros and cons of breast screening as well as what signs and symptoms they need to look out for.

“We also need to dispel some of the myths around breast cancer – it’s not a death sentence and more women are surviving this disease than ever before. This in turn will reduce women’s fear of the disease. The earlier breast cancer is diagnosed, the better the chance of survival so women shouldn’t be afraid of going to the doctor with symptoms or going for regular mammograms.”

Dr Jane Cope, director of the NCRI, said: “This is important research to help understand what is putting off some women going for . Every year over 48,000 women are diagnosed with and around 12,000 die from the disease.”

Explore further: Breast cancer patients lack adequate fertility preservation advice

More information: *Symptoms include a lump or thickening in an area of the breast; change in the size or shape of the breast; dimpling of the skin; a change in the shape of the nipple, particularly if it turns in, sinks into the breast or becomes irregular in shape; blood stained discharge from the nipple; a rash on the nipple or surrounding area; swelling or lump in the armpit.

Related Stories

Breast cancer patients lack adequate fertility preservation advice

November 7, 2011
(Medical Xpress) -- Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in ...

Researcher calls for mammograms to be tailored to patient

September 30, 2011
Mammograms are not one-size-fits-all, says noted breast cancer researcher Karla Kerlikowske, MD, of the University of California, San Francisco (UCSF). Rather, they should be customized based on a woman’s age, breast ...

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.